Dorsolateral prefrontal cortex: a possible target for modulating dyskinesias in Parkinson's disease by repetitive transcranial magnetic stimulation

I Rektorova, S Sedlackova, S Telecka, A Hlubocky, I Rektor, I Rektorova, S Sedlackova, S Telecka, A Hlubocky, I Rektor

Abstract

We studied whether five sessions of 10 Hz repetitive transcranial magnetic stimulation (rTMS treatment) applied over the dorsolateral prefrontal cortex (DLPFC) or the primary motor cortex (MC) in advanced Parkinson's disease (PD) patients would have any effect on L-dopa-induced dyskinesias and cortical excitability. We aimed at a randomised, controlled study. Single-pulse transcranial magnetic stimulation (TMS), paired-pulse transcranial magnetic stimulation, and the Unified Parkinson's Disease Rating Scale (UPDRS parts III and IV) were performed prior to, immediately after, and one week after an appropriate rTMS treatment. Stimulation of the left DLPFC induced a significant motor cortex depression and a trend towards the improvement of L-dopa-induced dyskinesias.

References

    1. Marconi R, Lefebvre-Caparros D, Bonnet A-M, Vidailhet M, Dubois B, Agid Y. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology. Movement Disorders. 1994;9(1):2–12.
    1. Rascol O, Sabatini U, Brefel C, et al. Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia. Brain. 1998;121(3):527–533.
    1. Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. The New England Journal of Medicine. 2000;342(20):1484–1491.
    1. Koch G, Brusa L, Caltagirone C, et al. rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease. Neurology. 2005;65(4):623–625.
    1. Piccini P, Weeks RA, Brooks DJ. Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias. Annals of Neurology. 1997;42(5):720–726.
    1. Bezard E, Brotchie JM, Gross CE. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nature Reviews Neuroscience. 2001;2(8):577–588.
    1. Obeso JA, Rodriguez-Oroz MC, Rodriguez M, DeLong MR, Olanow CW. Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model. Annals of Neurology. 2000;47(4, supplement 1):S22–S34.
    1. Lozano AM, Lang AE, Levy R, Hutchison W, Dostrovsky J. Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine. Annals of Neurology. 2000;47(4, supplement 1):S141–S146.
    1. Brooks DJ, Piccini P, Turjanski N, Samuel M. Neuroimaging of dyskinesia. Annals of Neurology. 2000;47(4, supplement 1):S154–S158.
    1. Siebner HR, Rothwell J. Transcranial magnetic stimulation: new insights into representational cortical plasticity. Experimental Brain Research. 2003;148(1):1–16.
    1. Pascual-Leone A, Valls-Solé J, Brasil-Neto JP, Cammarota A, Grafman J, Hallett M. Akinesia in Parkinson's disease. II. Effects of subthreshold repetitive transcranial motor cortex stimulation. Neurology. 1994;44(5):892–898.
    1. Cantello R, Tarletti R, Civardi C. Transcranial magnetic stimulation and Parkinson's disease. Brain Research Reviews. 2002;38(3):309–327.
    1. Lefaucheur J-P. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation. Clinical Neurophysiology. 2005;116(2):244–253.
    1. Lomarev MP, Kanchana S, Bara-Jimenez W, Iyer M, Wassermann EM, Hallett M. Placebo-controlled study of rTMS for the treatment of Parkinson's disease. Movement Disorders. 2006;21(3):325–331.
    1. Strafella AP, Ko JH, Monchi O. Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation. NeuroImage. 2006;31(4):1666–1672.
    1. Brusa L, Versace V, Koch G, et al. Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's disease. Clinical Neurophysiology. 2006;117(9):1917–1921.
    1. Wagle-Shukla A, Angel MJ, Zadikoff C, et al. Low-frequency repetitive transcranial magnetic stimulation for treatment of levodopa-induced dyskinesias. Neurology. 2007;68(9):704–705.
    1. Rektorova I, Sedlackova S, Telecka S, Hlubocky A, Rektor I. Repetitive transcranial stimulation for freezing of gait in Parkinson's disease. Movement Disorders. 2007;22(10):1518–1519.
    1. Strafella AP, Paus T, Fraraccio M, Dagher A. Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex. Brain. 2003;126(12):2609–2615.
    1. Strafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. Journal of Neuroscience. 2001;21(15):RC157.
    1. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry. 1988;51(6):745–752.
    1. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. Journal of Neurology Neurosurgery and Psychiatry. 1992;55(3):181–184.
    1. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427–442.
    1. Folstein MF, Folstein SE, McHugh PR. “Mini mental state” a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975;12(3):189–198.
    1. Montgomery SA, Asberg MA. A new depression scale designed to be sensitive to change. The British Journal of Psychiatry. 1979;134:382–389.
    1. George MS, Wassermann EM, Kimbrell TA, et al. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. American Journal of Psychiatry. 1997;154(12):1752–1756.
    1. Petrides M, Pandya DN. Dorsolateral prefrontal cortex: comparative cytoarchitectonic analysis in the human and the macaque brain and corticocortical connection patterns. European Journal of Neuroscience. 1999;11(3):1011–1036.
    1. Fahn S, Elston RL. Unified Parkinson's disease rating sscale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, editors. Recent Developments in Parkinson's Disease. Vol. 2. New York, NY, USA: Macmillan; 1987. pp. 153–163.
    1. Ridding MC, Inzelberg R, Rothwell JC. Changes in excitability of motor cortical circuitry patients with Parkinson's disease. Annals of Neurology. 1995;37(2):181–188.
    1. Bareš M, Kaňovský P, Klajblová H, Rektor I. Intracortical inhibition and facilitation are impaired in patients with early Parkinson's disease: a paired TMS study. European Journal of Neurology. 2003;10(4):385–389.
    1. Fitzgerald PB, Fountain S, Daskalakis ZJ. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clinical Neurophysiology. 2006;117(12):2584–2596.
    1. Rollnik JD, Schubert M, Dengler R. Subthreshold prefrontal repetitive transcranial magnetic stimulation reduces motor cortex excitability. Muscle and Nerve. 2000;23(1):112–114.
    1. Sakai K, Hikosaka O, Miyauchi S, Takino R, Sasaki Y, Pütz B. Transition of brain activation from frontal to parietal areas in visuomotor sequence learning. Journal of Neuroscience. 1998;18(5):1827–1840.
    1. Haslinger B, Kalteis K, Boecker H, Alesch F, Ceballos-Baumann AO. Frequency-correlated decreases of motor cortex activity associated with subthalamic nucleus stimulation in Parkinson's disease. NeuroImage. 2005;28(3):598–606.
    1. Sabatini U, Boulanouar K, Fabre N, et al. Cortical motor reorganization in akinetic patients with Parkinson's disease. a functional MRI study. Brain. 2000;123(2):394–403.
    1. Chen R, Garg RR, Lozano AM, Lang AE. Effects of internal globus pallidus stimulation on motor cortex excitability. Neurology. 2001;56(6):716–723.
    1. Modugno N, Curra A, Gilio F, Lorenzano C, Bagnato S, Berardeli A. Transcranial magnetic stimulation in movement disordes. In: Hallett M, Chokroverty S, editors. Magnetic Stimulation in Clinical Neurophysiology. 2nd. Philadelphia, Pa, USA: Elsevier; 2005. pp. 181–191.
    1. Payoux P, Remy P, Damier P, et al. Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease. Archives of Neurology. 2004;61(8):1307–1313.
    1. Goetz CG, Poewe W, Rascol O, Sampaio C. Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Movement Disorders. 2005;20(5):523–539.
    1. Knoch D, Treyer V, Regard M, Müri RM, Buck A, Weber B. Lateralized and frequency-dependent effects of prefrontal rTMS on regional cerebral blood flow. NeuroImage. 2006;31(2):641–648.
    1. Jahanshahi M, Jenkins IH, Brown RG, Marsden CD, Passingham RE, Brooks DJ. Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain. 1995;118(4):913–933.
    1. Playford ED, Jenkins IH, Passingham RE, Nutt J, Frackowiak RSJ, Brooks DJ. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Annals of Neurology. 1992;32(2):151–161.
    1. Haegelen C, Verin M, Broche BA, et al. Does subthalamic nucleus stimulation affect the frontal limbic areas? A single-photon emission computed tomography study using a manual anatomical segmentation method. Surgical and Radiologic Anatomy. 2005;27(5):389–394.
    1. Samuel M, Ceballos-Baumann AO, Turjanski N, et al. Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2O15 PET study. Brain. 1997;120(8):1301–1313.
    1. Thobois S, Guillouet S, Broussolle E. Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease. Neurophysiologie Clinique. 2001;31(5):321–340.
    1. Bates JF, Goldman-Rakic PS. Prefrontal connections of medial motor areas in the rhesus monkey. Journal of Comparative Neurology. 1993;336(2):211–228.
    1. Limousin P, Greene J, Pollak P, Rothwell J, Benabid A-L, Frackowiak R. Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Annals of Neurology. 1997;42(3):283–291.
    1. Eidelberg D, Moeller JR, Ishikawa T, et al. Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease. Annals of Neurology. 1996;39(4):450–459.
    1. Jenkins IH, Fernandez W, Playford ED, et al. Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Annals of Neurology. 1992;32(6):749–757.
    1. Lozano AM, Lang AE, Galvez-Jimenez N, et al. Effect of GPi pallidotomy on motor function in Parkinson's disease. The Lancet. 1995;346(8987):1383–1387.
    1. Katzenschlager R, Hughes A, Evans A, et al. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges. Movement Disorders. 2005;20(2):151–157.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir